Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $699M bought by 128 insiders at 87 companies
- $1.3B sold by 80 insiders outside a trading plan
- $1B sold by 336 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past week · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$247M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.4M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$66.3M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$62M
-
GMEGameStop CorporationRyan CohenCEO$17.1M
-
AVRAnteris Technologies Global Corp.L1 Capital Pty Ltd10% owner$9.7M
-
BORRBorr Drilling LimitedTor Olav TroimDirector$6.2M
-
PAMPampa Energia S.A.Damian Miguel MindlinVicepresident$5.6M
-
GPUSHyperscale Data, Inc.Milton C Ault IIIChair · +1 joint filer$5.1M
Biggest sales
Past week · by insider, all their filings added up · planned sales marked
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
-
ESTCElastic N.V.Steven SchuurmanDirector$135M
-
NBISNebius Group N.V.Ophir NaveCOO$118M
-
CBRSCerebras Systems Inc.Dhiraj MallickCOO$80.8M
-
CRWDCrowdStrike Holdings, Inc.Michael SentonasPresident$64.2M
-
AAPLApple Inc ComTimothy D CookChair$63.8M
-
MPWRMonolithic Power Systems, Inc.Michael HsingCEO$40.3M
-
ACTEnact Holdings, Inc.Genworth Holdings, Inc.10% owner$37.1M
-
WDAYWorkday, Inc.David A Duffield10% owner$37.1M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Oluyemi Okupe CFOHIMSHims & Hers Health, Inc.Planned sale$59K 2,000 shares at $29.70 0.8% of stakeTraded Oct 1 Filed Oct 2
-
Soleil Boughton Chief Legal OfficerHIMSHims & Hers Health, Inc.Planned sale$101K 3,461 shares at $29.17 1.1% of stakeTraded Sep 30 Filed Oct 2
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$5.5M 9,500 shares at $576.47 2.8% of stakeTraded Oct 1 Filed Oct 2
-
Tim Foote CFOBBBlackBerry LimitedSale$152K 16,672 shares at $9.14 23% of stakeTraded Oct 1 Filed Oct 2
-
Philip S. Kurtz CLO & Corp. SecretaryBBBlackBerry LimitedSale$274K 30,000 shares at $9.14 32% of stakeTraded Sep 30 Filed Oct 2
-
Darren Sherman See RemarksOBIOOrchestra BioMed Holdings, Inc.Planned sale$95K 15,000 shares at $6.36 1.3% of stakeTraded Oct 1 Filed Oct 2
-
Glenn Coleman CFOCRLCharles River Laboratories International, Inc.Buy$2,974 10 shares at $297.43 +<0.1% to stakeTraded Sep 30 Filed Oct 2
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$3.3M 34,000 shares at $97.09 16% of stakeTraded Oct 1–2 Filed Oct 2
-
Sarah Elizabeth Schubach Chief Accounting OfficerDBXDropbox, Inc.Planned sale$66K 2,025 shares at $32.54 1.5% of stakeTraded Sep 30 Filed Oct 2
-
Carol Ann Clements Chief Digital & Tech OfficerJBLUJetBlue Airways CorporationPlanned sale$8,580 2,000 shares at $4.29 1.1% of stakeTraded Sep 30 Filed Oct 2
-
Samak L Azar Chief Legal OfficerGFSGlobalFoundries Inc.Planned sale$16K 335 shares at $47.92 3.7% of stakeTraded Oct 1 Filed Oct 2
-
John Sheldon Serafini CEOHAWKHawkEye 360, Inc.Planned sale$1.4M 92,329 shares at $14.78 14% of stakeTraded Oct 1 Filed Oct 2
-
Alina Kerdman SVP, Controller & CAOCTSHCognizant Technology Solutions CorporationPlanned sale$7,906 139 shares at $56.88 11% of stakeTraded Sep 30 Filed Oct 2
-
Wajid Ali CFOLITELumentum Holdings Inc.Planned sale$25.7M 24,542 shares at $1,048.50 25% of stakeTraded Oct 1 Filed Oct 2
-
Conor Murphy CEOFGF&G Annuities & Life, Inc.Buy$5,015 231 shares at $21.68 +0.1% to stakeTraded Sep 30 Filed Oct 2
-
Darren S Raiguel COOPLUSePlus inc.Planned sale$558 6 shares at $93.01 <0.1% of stakeTraded Oct 1 Filed Oct 2
-
Edward Meyercord CEOEXTRExtreme Networks, Inc.Planned sale$1.1M 50,000 shares at $21.77 2.8% of stakeTraded Oct 1 Filed Oct 2
-
Jason V Coloma CEOMAZEMaze Therapeutics, Inc.Planned sale$932K 34,501 shares at $27.02 15% of stakeTraded Oct 1 Filed Oct 2
-
Jennifer Tejada ChairPDPagerDuty, Inc.Planned sale$1.6M 107,000 shares at $15.11 6.4% of stakeTraded Sep 30 Filed Oct 2
-
Asif Ali CFOPTGXProtagonist Therapeutics, Inc.Planned sale$8.3M 58,629 shares at $141.78 50% of stakeTraded Sep 30 Filed Oct 2
-
Harold Bernstein President, R&D & CMOMAZEMaze Therapeutics, Inc.Planned sale$435K 16,141 shares at $26.93 100% of stakeTraded Oct 1 Filed Oct 2
-
William D Mosley CEOSTXSeagate Technology Hldngs PlPlanned sale$10.3M 11,002 shares at $935.60 2.9% of stakeTraded Oct 1 Filed Oct 2
-
William D Mosley CEOSTXSeagate Technology Hldngs PlPlanned sale$17.4M 18,998 shares at $914.67 4.8% of stakeTraded Oct 1 Filed Oct 2
-
Lee Shavel CEOVRSKVerisk Analytics, Inc.Planned sale$603K 3,535 shares at $170.70 3.5% of stakeTraded Oct 1 Filed Oct 2
-
Anita Gonzales VP and CAORVTYRevvity, Inc.Planned sale$13K 84 shares at $155.48 1.2% of stakeTraded Oct 1 Filed Oct 2
-
Matthew Siegel CFOOUTOUTFRONT Media Inc.Planned sale$696K 25,000 shares at $27.84 8.6% of stakeTraded Oct 1 Filed Oct 2
-
Vikas Bhalla President of EXLEXLSExlService Holdings, Inc.Planned sale$389K 11,000 shares at $35.38 9.1% of stakeTraded Oct 1 Filed Oct 2
-
James Edward Sklar EVP, Gen Counsel & SecretaryHGBLHeritage Global Inc.Planned sale$3,175 2,500 shares at $1.27 1% of stakeTraded Oct 1 Filed Oct 2
-
Ralph A LaRossa CEOPEGPublic Service Enterprise Group IncorporatedPlanned sale$141K 2,083 shares at $67.48 0.7% of stakeTraded Oct 1 Filed Oct 2
-
Lawrence T. Oliver Senior VP and SecretaryRGCORGC Resources Inc.Buy$200 9 shares at $21.59 +<0.1% to stakeTraded Oct 1 Filed Oct 2
-
Christen Brooke Miles VP, Human ResourcesRGCORGC Resources Inc.Buy$100 5 shares at $21.59 +<0.1% to stakeTraded Oct 1 Filed Oct 2
-
Terrance Lane Wilson SVP & General CounselWMBWilliams Companies, Inc. (The)Planned sale$136K 2,000 shares at $67.85 0.8% of stakeTraded Oct 1 Filed Oct 2
-
Robert D Vilsack Secretary & CLOPKOHPark-Ohio Holdings Corp.Planned sale$148K 3,190 shares at $46.42 2.2% of stakeTraded Oct 1 Filed Oct 2
-
Robert D Vilsack Secretary & CLOPKOHPark-Ohio Holdings Corp.Planned sale$207K 4,544 shares at $45.58 3% of stakeTraded Oct 1 Filed Oct 2
-
Francisco Gonzalez CFOSKYHSky Harbour Group CorporationBuy$15K 1,600 shares at $9.40 +0.2% to stakeTraded Oct 1 Filed Oct 2
-
John T Hall CEOINTAIntapp, Inc.Planned sale$110K 3,000 shares at $36.70 0.1% of stakeTraded Sep 30–Oct 1 Filed Oct 2
-
Yair Nechmad ChairNYAXNayax Ltd.Buy$2.1M 44,148 shares at $47.84 +0.6% to stakeTraded Sep 30 Filed Oct 2
-
David J. Bates COOXPOXPO, Inc.Planned sale$465K 2,615 shares at $177.93 4% of stakeTraded Oct 1 Filed Oct 2
-
Kyle Wismans CFOXPOXPO, Inc.Planned sale$132K 750 shares at $175.47 1.5% of stakeTraded Oct 1 Filed Oct 2
-
Neil Lerner Chief Accounting OfficerCMPXCompass Therapeutics, Inc.Buy$18K 20,000 shares at $0.9200 +5% to stakeTraded Oct 1 Filed Oct 2
-
Kun Dai CEOUXINUxin LimitedBuy$13K 9,000 shares at $1.42 +57% to stakeTraded Oct 1 Filed Oct 2
-
Fang Jiang Chief People OfficerBABAAlibaba Group Holding LimitedSale$12M 885,272 shares at $13.55 16% of stakeTraded Sep 30 Filed Oct 2
-
Satish Dhanasekaran CEOKEYSKeysight Technologies Inc.Sale$1.1M 3,000 shares at $364.13 2.5% of stakeTraded Sep 30 Filed Oct 2
-
Nicholas Conrad Smith CFOANROAlto Neuroscience, Inc.Planned sale$3.6M 134,886 shares at $26.45 85% of stakeTraded Sep 29–30 Filed Oct 1
-
Chris Koopmans COOMRVLMarvell Technology, Inc.Planned sale$2.6M 10,000 shares at $262.05 4.6% of stakeTraded Oct 1 Filed Oct 1
-
Taylor Monnig COOCLSKCleanSpark, Inc.Planned sale$41K 3,335 shares at $12.33 1% of stakeTraded Oct 1 Filed Oct 1
-
Sanjit Biswas CEOIOTSamsara Inc.Planned sale$10M 263,900 shares at $38.03 23% of stakeTraded Sep 29–Oct 1 Filed Oct 1
-
John Bicket See RemarksIOTSamsara Inc.Planned sale$10M 263,900 shares at $38.03 21% of stakeTraded Sep 29–Oct 1 Filed Oct 1
-
Greg Cavers CFOHELPCybin Inc.Buy$39K 3,000 shares at $12.91 New stakeTraded Sep 29 Filed Oct 1
-
James W Bernau PresidentWVVIWillamette Valley Vineyards, Inc.Buy$9,491 5,500 shares at $1.73 +1.5% to stakeTraded Oct 1 Filed Oct 1
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.